Field-practice study of sorafenib therap
โ
Massimo Iavarone; Giuseppe Cabibbo; Fabio Piscaglia; Claudio Zavaglia; Antonio G
๐
Article
๐
2011
๐
John Wiley and Sons
๐
English
โ 229 KB
๐ 2 views
on behalf of the SOFIA (SOraFenib Italian Assessment) study group A multicenter randomized controlled trial established sorafenib as a standard of care for patients with advanced hepatocellular carcinoma (HCC). Because the study was prematurely interrupted due to survival benefits in the sorafenib a